Cleared Traditional

K073062 - OMNI-VUE SYSTEM

K073062 is an FDA 510(k) clearance for OMNI-VUE SYSTEM, manufactured by Genesis Digital Imaging, Inc.. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 132-day FDA review.

K073062 · Genesis Digital Imaging, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2008
Decision
132d
Days
Class 2
Risk

K073062 is an FDA 510(k) clearance for the OMNI-VUE SYSTEM. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Genesis Digital Imaging, Inc. (Denton, US). The FDA issued a Cleared decision on March 10, 2008 after a review of 132 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Genesis Digital Imaging, Inc. devices

FDA 510(k) Submission Details - K073062

510(k) Number K073062 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 30, 2007
Decision Date March 10, 2008
Days to Decision 132 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
25d slower than avg
Panel avg: 107d · This submission: 132d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1260
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K073062.
SURGICASE
K073449 · Materialise NV · Apr 2008
MIMICS
K073468 · Materialise NV · Apr 2008
COLOR LCD MONITOR, MODEL RADIFORCE RX211
K080457 · Eizo Nanao Corporation · Mar 2008
5 MEGAPIXEL MONOCHROME LCD MONITOR, MODEL RADIFORCE GS520
K080422 · Eizo Nanao Corporation · Mar 2008
SYNGO IMAGING CCF VA10A
K073418 · Siemens AG Medical Solutions · Feb 2008
I-DIXEL
K073704 · J. Morita USA, Inc. · Feb 2008